The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Bowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Chiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
The role of GABA in anxiety disorders.
Lydiard, R. B. (2003) · PubMed · Cited by 535
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
Klitgaard, H., Matagne, A., Gobert, J., & Wülfert, E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00410-5 · Cited by 506
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Rosenthal, N. R., Karim, M. R., Kamin, M., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.255 · Cited by 484
Severe persistent visual field constriction associated with vigabatrin: FIG 1
Eke, T., Talbot, J. F., & Lawden, M. C. (1997) · BMJ · doi:10.1136/bmj.314.7075.180 · Cited by 447
Ohayon, M. M. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00002-2 · Cited by 423
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415
Efficacy of Felbamate in Childhood Epileptic Encephalopathy (Lennox-Gastaut Syndrome)
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280105 · Cited by 407
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
Janz, R., Goda, Y., Geppert, M., Missler, M., & Südhof, T. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)81046-6 · Cited by 367
Bray, G. A., Hollander, P., Klein, S., Kushner, R., Levy, B., Fitchet, M., & Perry, B. H. (2003) · Obesity Research · doi:10.1038/oby.2003.102 · Cited by 344
Fehrenbacher, J. C., Taylor, C. P., & Vasko, M. R. (2003) · Pain · doi:10.1016/s0304-3959(03)00173-8 · Cited by 336
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
Borden, L. A., Dhar, T. G. M., Smith, K. E., Weinshank, R. L., Branchek, T. A., & Gluchowski, C. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90089-2 · Cited by 334
Lauria-Horner, B. A., & Pohl, R. B. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.663 · Cited by 327
Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial
Pande, A. C., Crockatt, J. G., Feltner, D. E., Janney, C. A., Smith, W. T., Weisler, R., Londborg, P. D., Bielski, R. J., Zimbroff, D. L., Davidson, J. R. T., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.533 · Cited by 314
Psychiatric adverse events during levetiracetam therapy
Mula, M., Trimble, M., Yuen, A. W. C., Liu, R. S. N., & Sander, J. W. A. S. (2003) · Neurology · doi:10.1212/01.wnl.0000078031.32904.0d · Cited by 282
Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., Liu-Dumaw, M., Carter, C. M., & Pande, A. C. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084032.22282.ff · Cited by 260
Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function
Randinitis, E. J., Posvar, E. L., Alvey, C. W., Sedman, A. J., Cook, J. A., & Bockbrader, H. N. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003251119 · Cited by 257
A review of functional neuroimaging studies of vagus nerve stimulation (VNS)
Chae, J.-H., Nahas, Z., Lomarev, M., Denslow, S., Lorberbaum, J. P., Bohning, D. E., & George, M. S. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00074-8 · Cited by 255
Oral contraceptives reduce lamotrigine plasma levels
Sabers, A., Öhman, I., Christensen, J., & Tomson, T. (2003) · Neurology · doi:10.1212/01.wnl.0000076485.09353.7a · Cited by 250
Self-citationPrivitera, M. D., Brodie, M. J., Mattson, R. H., Chadwick, D. W., Neto, W., Wang, S., & for the EPMN 105 Study Group (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00093.x · Cited by 249
Rundfeldt, C., & Netzer, R. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00866-1 · Cited by 242
Lamotrigine clearance during pregnancy
Tran, T. A., Leppik, I. E., Blesi, K., Sathanandan, S. T., & Remmel, R. (2002) · Neurology · doi:10.1212/wnl.59.2.251 · Cited by 241
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
Rostock, A., Tober, C., Rundfeldt, C., Bartsch, R., Engel, J., Polymeropoulos, E. E., Kutscher, B., Löscher, W., Hönack, D., White, H. S., et al. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00101-8 · Cited by 240
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures
French, J. A., Kugler, A. R., Robbins, J. L., Knapp, L. E., & Garofalo, E. A. (2003) · Neurology · doi:10.1212/01.wnl.0000068024.20285.65 · Cited by 239
Kenda, B. M., Matagne, A. C., Talaga, P. E., Pasau, P. M., Differding, E., Lallemand, B. I., Frycia, A. M., Moureau, F. G., Klitgaard, H. V., Gillard, M. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030913e · Cited by 226
The impact of pregnancy and childbirth on the metabolism of lamotrigine
Pennell, P. B., Newport, D. J., Stowe, Z. N., Helmers, S. L., Montgomery, J. Q., & Henry, T. R. (2004) · Neurology · doi:10.1212/01.wnl.0000103286.47129.f8 · Cited by 223
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures
Faught, E., Ayala, R., Montouris, G. G., Leppik, I. E., & the Zonisamide 922 Trial Group (2001) · Neurology · doi:10.1212/wnl.57.10.1774 · Cited by 222
Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39009-3 · Cited by 217
Gryder, D. S., & Rogawski, M. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07069.2003 · Cited by 216
Blackburn-Munro, G., & Jensen, B. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02924-2 · Cited by 208
Marrosu, F., Serra, A., Maleci, A., Puligheddu, M., Biggio, G., & Piga, M. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00107-4 · Cited by 206
Fink-Jensen, A., Suzdak, P. D., Swedberg, M. D. B., Judge, M. E., Hansen, L., & Nielsen, P. G. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90748-s · Cited by 185
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Far field potentials from the brain stem after transcutaneous vagus nerve stimulation
Fallgatter, A. J., Neuhauser, B., Herrmann, M. J., Ehlis, A.-C., Wagener, A., Scheuerpflug, P., Reiners, K., & Riederer, P. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0087-6 · Cited by 184
Pharmacokinetic Interactions of Topiramate
Bialer, M., Doose, D. R., Murthy, B., Curtin, C., Wang, S.-S., Twyman, R. E., & Schwabe, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443120-00001 · Cited by 182
Self-citationDooley, D. J., Donovan, C. M., Meder, W. P., & Whetzel, S. Z. (2002) · Synapse · doi:10.1002/syn.10094 · Cited by 180
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00108-9 · Cited by 179
Self-citationEffects of Vagus Nerve Stimulation on Sleep‐related Breathing in Epilepsy Patients
Marzec, M., Edwards, J., Sagher, O., Fromes, G., & Malow, B. A. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.56202.x · Cited by 174
Herrero, A. I., Del Olmo, N., González-Escalada, J. R., & Solı́s, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00171-x · Cited by 174
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00106-7 · Cited by 172
Self-citationZakrzewska, J. M., & Patsalos, P. N. (2002) · Pain · doi:10.1016/s0304-3959(01)00406-7 · Cited by 166
Doose, D. R., Wang, S., Padmanabhan, M., Schwabe, S., Jacobs, D., & Bialer, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.55602.x · Cited by 161
Self-citationCerebral Activation during Vagus Nerve Stimulation: A Functional MR Study
Narayanan, J. T., Watts, R., Haddad, N., Labar, D. R., Li, P. M., & Filippi, C. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.16102.x · Cited by 159
Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
Klitgaard, H. (2001) · Epilepsia · doi:10.1111/j.1528-1167.2001.00003.x · Cited by 153
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00171-6 · Cited by 152
Self-citationStiripentol: Efficacy and Tolerability in Children with Epilepsy
Perez, J., Chiron, C., Musial, C., Rey, E., Blehaut, H., D'Athis, P., Vincent, J., & Dulac, O. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02048.x · Cited by 148
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability
Gidal, B. E., Radulovic, L. L., Kruger, S., Rutecki, P. A., Pitterle, M. E., & Bockbrader, H. N. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00117-0 · Cited by 145
Cramer, J. A., & Hammée, G. V. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00004-0 · Cited by 141
D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures
Tober, C., Rostock, A., Rundfeldt, C., & Bartsch, R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00073-8 · Cited by 139
Margineanu, D. G., & Klitgaard, H. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0689 · Cited by 135
Sackellares, J. C., Ramsay, R. E., Wilder, B. J., Browne, T. R., & Shellenberger, M. K. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.11403.x · Cited by 135
A double-blind placebo-controlled trial of topiramate treatment for essential tremor
Connor, G. S. (2002) · Neurology · doi:10.1212/wnl.59.1.132 · Cited by 132
Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity
Field, M. J., Oles, R. J., & Singh, L. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703794 · Cited by 129
The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects
Mathias, S., Wetter, T. C., Steiger, A., & Lancel, M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00232-3 · Cited by 128
Non-competitive AMPA Antagonists of 2,3-Benzodiazepine Type
Sólyom, S., & Tarnawa, I. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612024607081 · Cited by 116
Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain
Carrazana, E. J., & Mikoshiba, I. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00067-8 · Cited by 115
Tiagabine for the Treatment of Generalized Anxiety Disorder
Rosenthal, M. H. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1016 · Cited by 111
Gabapentin versus Lamotrigine Monotherapy: A Double‐blind Comparison in Newly Diagnosed Epilepsy
Brodie, M. J., Chadwick, D. W., Anhut, H., Otte, A., Messmer, S., Maton, S., Sauermann, W., Murray, G., Garofalo, E. A., & for the Gabapentin Study Group 945‐212 (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.45401.x · Cited by 110
Tran, A., Rey, E., Pons, G., Rousseau, M., d’Athis, P., Olivé, G., MATHER, G. G., Bishop, F. E., Wurden, C. J., Labroo, R. B., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90044-8 · Cited by 110
Self-citationFox, A., Gentry, C., Patel, S., Kesingland, A., & Bevan, S. (2003) · Pain · doi:10.1016/s0304-3959(03)00253-7 · Cited by 108
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy
Kutluay, E., McCague, K., D’Souza, J., & Beydoun, A. A. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00037-4 · Cited by 107
Perucca, E., Gidal, B. E., & Baltes, E. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00250-4 · Cited by 106
Self-citationHuman Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
Blanco, J. G., Harrison, P. L., Evans, W. E., & Relling, M. V. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15052-0 · Cited by 102
Morrell, M. J., Leppik, I. E., French, J. A., Ferrendelli, J. A., Han, J. Y., & Magnus, L. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00080-9 · Cited by 100
Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy
Renfroe, J. B., & Wheless, J. W. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s26 · Cited by 100
Effects of oxcarbazepine on sodium concentration and water handling
Sachdeo, R. C., Wasserstein, A. G., Mesenbrink, P. J., & D’Souza, J. (2002) · Annals of Neurology · doi:10.1002/ana.10190 · Cited by 100
Jolkkonen, J., Puurunen, K., Rantakömi, S. H., Härkönen, A., Haapalinna, A., & Sivenius, J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00409-x · Cited by 99
Stiripentol kinetics in epilepsy: Nonlinearity and interactions
Levy, R. H., Loiseau, P., Guyot, M., Bléhaut, H., Tor, J., & Moreland, T. A. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.237 · Cited by 99
Self-citationVonck, K. E. J., Boon, P., Laere, K. V., D’Havé, M., Vandekerckhove, T., O'Connor, S., Brans, B. T., Dierckx, R. A., & Reuck, J. D. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00215.x · Cited by 97
Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development.
Gellman, R. L., Kallianos, J. A., & McNamara, J. O. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00197-1 · Cited by 97
2,3‐Benzodiazepines (GYKI 52466 and Analogs): Negative Allosteric Modulators of AMPA Receptors
Vizi, E. S., Mike, Á., & Tarnawa, I. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00292.x · Cited by 96
A crossover, add-on trial of talampanel in patients with refractory partial seizures
Chappell, A. S., Sander, J. W. A. S., Brodie, M. J., Chadwick, D., Lledó, A., Zhang, D., Bjerke, J. S., Kiesler, G. M., & Arroyo, S. (2002) · Neurology · doi:10.1212/wnl.58.11.1680 · Cited by 95
Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model
Stratton, S. C., Large, C. H., Cox, B. J., Davies, G., & Hagan, R. M. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00254-1 · Cited by 91
Metabolism of Retigabine (D-23129), a Novel Anticonvulsant
Hempel, R., Schupke, H., McNeilly, P. J., Heinecke, K., Kronbach, C., Grunwald, C., Zimmermann, G., Griesinger, C., Engel, J., & Kronbach, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15258-0 · Cited by 90
BOLD fMRI activation induced by vagus nerve stimulation in seizure patients
Liu, W.-C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.811 · Cited by 89
Haapalinna, A., Viitamaa, T., MacDonald, E., Savola, J., Tuomisto, L. M., Virtanen, R., & Heinonen, E. H. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005092 · Cited by 86
Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers
Ferron‐Brady, G., Paul, J., Fruncillo, R. J., Richards, L. S., Knebel, N. G., Getsy, J. A., & Troy, S. M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011210 · Cited by 86
Long-term outcome of vagus nerve stimulation for refractory partial epilepsy
Chavel, S. M., Westerveld, M., & Spencer, S. S. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00109-4 · Cited by 85
Nallani, S. C., Glauser, T. A., Hariparsad, N., Setchell, K. D. R., Buckley, D. J., Buckley, A. R., & Desai, P. B. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.06203.x · Cited by 83
Effect of Vagal Nerve Stimulation on Interictal Epileptiform Discharges: A Scalp EEG Study
Kuba, R., Guzaninová, M., Brázdil, M., Novák, Z., Chrastina, J., & Rektor, I. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.08202.x · Cited by 82
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy
Ben‐Menachem, E., Edrich, P., Vleymen, B. V., Sander, J. W. A. S., & Schmidt, B. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00247-4 · Cited by 80
Effect of levetiracetam in refractory childhood epilepsy syndromes
Lagae, L. G., Buyse, G., Deconinck, A., & Ceulemans, B. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(03)00041-2 · Cited by 79
RING, H. A., White, S., Costa, D. C., Pottinger, R., Dick, J., Koeze, T. H., & Sutcliffe, J. (2000) · Seizure · doi:10.1053/seiz.2000.0438 · Cited by 79
Aldenkamp, A. P., Majoie, M., Berfelo, M. W., Evers, S., Kessels, A. G. H., Renier, W. O., & Wilmink, J. T. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00517-6 · Cited by 76
Morris, G. L. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.08.025 · Cited by 75
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode
Benedetti, A. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00407-x · Cited by 74
Preclinical Evaluation of PNU-151774E as a Novel Anticonvulsant
Fariello, R. G., McArthur, R. A., Bonsignori, A., Cervini, M. A., Maj, R., Marrari, P., Pevarello, P., Wolf, H. H., Woodhead, J., White, H. S., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37430-0 · Cited by 72
Vigabatrin, the GABA‐transaminase inhibitor, damages cone photoreceptors in rats
Duboc, A., Hanoteau, N., Simonutti, M., Rudolf, G., Nehlig, A., Sahel, J., & Picaud, S. A. (2004) · Annals of Neurology · doi:10.1002/ana.20081 · Cited by 71
Engel, J., Wilson, C. L., & Bragin, A. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.12002.x · Cited by 71
Levetiracetam treatment of idiopathic generalised epilepsy
Krauss, G. L., Betts, T., Abou-Khalil, B. W., Bergey, G. K., YARROW, H., & Miller, A. (2003) · Seizure · doi:10.1016/s1059-1311(03)00139-0 · Cited by 70
Coupez, R., Nicolas, J., & Browne, T. R. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.25302.x · Cited by 69
Halonen, T., Kotti, T. J., Tuunanen, J., Toppinen, A., Miettinen, R. A., & Riekkinen, P. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00744-b · Cited by 67
Janumpalli, S., Butler, L. S., MacMillan, L. B., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02004.1998 · Cited by 66
A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study.
Poisson, M., Huguet, F., Savattier, A., BAKRI‐LOGEAIS, F., & Narcisse, G. (1984) · PubMed · Cited by 65
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats
Ardid, D., Lamberty, Y., Alloui, A., Coudoré‐Civiale, M., Klitgaard, H., & Eschalier, A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01933-2 · Cited by 64
Cloyd, J. C., Dutta, S., Cao, G., Walch, J. K., Collins, S. D., & Granneman, G. R. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00251-6 · Cited by 64
Magdaleno-Madrigal, V. M., Valdés‐Cruz, A., Martínez-Vargas, D., Martínez, A., Almazán‐Alvarado, S., Fernández‐Mas, R., & Fernández‐Guardiola, A. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.05702.x · Cited by 63
Dutta, S., Zhang, Y., Selness, D. S., Lee, L. L., Williams, L. A., & Sommerville, K. W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00007-4 · Cited by 63
Noradrenergic modulation of human cortex excitability by the presynaptic α2-antagonist yohimbine
Plewnia, C., Bartels, M., Cohen, L. G., & Gerloff, C. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01921-8 · Cited by 63
Ambrósio, A. F., Silva, A. P., Araújo, I. M., Malva, J. O., Soares-da-Silva, P., Carvalho, A. P., & Carvalho, C. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00659-2 · Cited by 62
Barnes, A., Duncan, R., Chisholm, J. A., Lindsay, K. W., Patterson, J. C., & Wyper, D. J. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1026-8 · Cited by 61
New non competitive AMPA antagonists
Ábrahám, G., Sólyom, S., Csuzdi, E., Berzsenyi, P., Ling, I., Tarnawa, I., Hámori, T., Pallagi, I., Horváth, K., Andrasi, F., et al. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00133-4 · Cited by 59
Doose, D. R., Brodie, M. J., Wilson, E. A., Chadwick, D. W., Oxbury, J. M., Berry, D. J., Schwabe, S., & Bialer, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.64402.x · Cited by 58
Self-citationMetabolic disposition of pregabalin in healthy volunteers
Corrigan, B., Pool, W. F., Posvar, E. L., Strand, J. C., Alvey, C. W., Radulovic, L. L., & Bockbrader, H. N. (2001) · Clinical Pharmacology & Therapeutics · Cited by 58
PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat
Maj, R., Fariello, R. G., Ukmar, G., Varasi, M., Pevarello, P., McArthur, R. A., & Salvati, P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00554-8 · Cited by 56
Topiramate alters excitatory synaptic transmission in mouse hippocampus
Qian, J., & Noebels, J. L. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00120-7 · Cited by 56
Widespread Upregulation of Drug‐resistance Proteins in Fatal Human Status Epilepticus
Sisodiya, S. M., & Thom, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.42802.x · Cited by 54
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human
Cazali, N., Tran, A., Tréluyer, J., Rey, E., d’Athis, P., Vincent, J., & Pons, G. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2003.01919.x · Cited by 53
Kapetanović, I. M., Torchin, C. D., Thompson, C. D., Miller, T. A., McNeilly, P. J., Macdonald, T. L., Kupferberg, H. J., Perhach, J. L., Sofia, R. D., & Strong, J. M. (1998) · PubMed · Cited by 49
Self-citationα2-adrenoceptors modulate kainic acid-induced limbic seizures
Baran, H., Sperk, G., Hörtnagl, H., Sapetschnig, G., & Hornykiewicz, O. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90744-7 · Cited by 48
Clinical experience of marketed Levetiracetam in an epilepsy clinic—a one year follow up study
Betts, T., YARROW, H., Greenhill, L., & BARRETT, M. (2003) · Seizure · doi:10.1016/s1059-1311(02)00258-3 · Cited by 48
Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19
Lakehal, F., Wurden, C. J., Kalhorn, T. F., et al. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00188-2 · Cited by 46
A controlled study comparing visual function in patients treated with vigabatrin and tiagabine
Krauss, G. L. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.3.339 · Cited by 45
Safety and tolerance of rapidly infused Depacon®
Ramsay, R. E., Cantrell, D. T. C., Collins, S. D., Walch, J. K., Naritoku, D. K., Cloyd, J. C., & Sommerville, K. W. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00187-0 · Cited by 42
Beydoun, A. A., Sachdeo, R. C., Kutluay, E., McCague, K., & D’Souza, J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.54102.x · Cited by 41
Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy
Kiguchi, S., Imamura, T., Ichikawa, K., et al. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03950.x · Cited by 41
Sommerville, K. W., Dutta, S., Biton, V., Zhang, Y., Cloyd, J. C., & Uthman, B. M. (2003) · Clinical Drug Investigation · doi:10.2165/00044011-200323100-00005 · Cited by 40
Almeida, L., & Soares-da-Silva, P. (2003) · Drugs in R&D · doi:10.2165/00126839-200304050-00001 · Cited by 36
Lindberger, M., Tomson, T., Wallstedt, L., & Ståhle, L. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.4220256.x · Cited by 36
Self-citationDutta, S., Reed, R. C., & Cavanaugh, J. H. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004266782 · Cited by 34
Levetiracetam monotherapy for newly diagnosed epilepsy patients
Alsaadi, T. M., & Thieman, C. (2003) · Seizure · doi:10.1016/s1059-1311(02)00274-1 · Cited by 33
Benedetti, M. S., Marrari, P., Colombo, M., et al. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03736.x · Cited by 33
Hussein, Z., Mukherjee, D., Lamm, J. E., Cavanaugh, J. H., & Granneman, G. R. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02036.x · Cited by 32
Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
Klitgaard, H. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.0420s4013.x · Cited by 32
Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus
Mazarati, A. M., Sofia, R. D., & Wasterlain, C. G. (2002) · Seizure · doi:10.1053/seiz.2002.0677 · Cited by 31
Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children
Tran, A., Vauzelle-Kervroedan, F., Rey, E., Pons, G., d'Athis, P., Chiron, C., Dulac, O., Renard, F., & Olivé, G. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050147 · Cited by 30
Horne, R. L., & Cunanan, C. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00010 · Cited by 29
Mervaala, E., Alhainen, K., Helkala, E.-L., Partanen, J. V., Jousmäki, V., Väyrynen, M., Heinonen, E., & Riekkinen, P. J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90010-n · Cited by 28
Velíšek, L., & Velíšková, J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.3.x · Cited by 28
Protective Effect of Stiripentol on Acetaminophen-Induced Hepatotoxicity in Rat
Tran, A., Tréluyer, J., Rey, E., Barbet, P., Ferracci, G., d’Athis, P., Vincent, J., & Pons, G. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9091 · Cited by 28
Anticonvulsant Activity of PNU‐151774E1 in the Amygdala Kindled Model of Complex Partial Seizures
Maj, R., Fariello, R. G., Pevarello, P., Varasi, M., McArthur, R. A., & Salvati, P. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02035.x · Cited by 25
Divalproex-ER pharmacokinetics in older children and adolescents
Dutta, S., Zhang, Y., Conway, J. M., Sallee, F. R., Biton, V., Reed, M. D., & Kearns, G. L. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.12.006 · Cited by 25
Future Prospects for the Drug Treatment of Epilepsy
Nicolson, A., & Leach, J. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115120-00005 · Cited by 25
Kapus, G. L., Székely, J. I., Durand, J., Ruiz, A. J., & Tarnawa, I. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00288-4 · Cited by 23
Ninth Cranial Nerve Stimulation for Epilepsy Control
Tubbs, R. S., Patwardhan, R. V., & Oakes, W. J. (2002) · Pediatric Neurosurgery · doi:10.1159/000058427 · Cited by 22
Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects.
Hui, A. C. F., Lam, J. M. K., Wong, K. S., Kay, R., & Poon, W. S. (2004) · PubMed · Cited by 22
Cunha, R. A., Coelho, J. E., Costenla, A. R., Lopes, L. V., Parada, A., de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900407.x · Cited by 20
Baptista, T., Kin, N. M. K. N. Y., & Beaulieu, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443010-00001 · Cited by 18
Fariello, R. G., Maj, R., Marrari, P., Beard, D., Algate, C., & Salvati, P. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00103-5 · Cited by 18
Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse model
Finnell, R. H., Bennett, G. D., Mather, G. G., Wlodarczyk, B. J., Bajpai, M., & Levy, R. H. (1999) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00067-7 · Cited by 16
Self-citationSymptomatic Hyponatremia in Patients on Oxcarbazepine Therapy for the Treatment of Neuropathic Pain
Adkoli, S. (2003) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v17n01_06 · Cited by 7
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Duncan, J. S., Sander, J. W., Sisodiya, S. M., & Walker, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68477-8 · Cited by 728
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Keri, R. S., Patil, M. R., Patil, S. A., & Budagumpi, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.059 · Cited by 631
Metadata
- Authors
- Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T.
- Venue
- Epilepsy Research
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 61
- Issue
- 1-3
- Pages
- 1-48
- ISSN
- 0920-1211 (ISSN-L)
- OpenAlex
- W2132812107
- Cited by
- 300
- References
- 147
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.